Novel Porous Bioceramic Material as a Bone Substitute

Orton Orthopaedic Hospital

Status: Terminated

Conditions: Alveolar Ridge Preservation

Treatments: Device: Adaptos® (bone grafting surgery); Device: Adaptos®-Si [1-2 mm] (bone grafting surgery); Device: Geistlich Bio-Oss (bone grafting surgery); Device: Adaptos®-Si [0.5-1 mm] (bone grafting surgery); Procedure: Tooth extraction without bone graft material

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04719624

AdaptosOral-001

Details and patient eligibility

About

The aim of this study is to demonstrate that new synthetic bone graft bioceramic composites (Adaptos®-Si and Adaptos®, Biomendex Oy) are able to support the preservation of the alveolar ridge and to promote bone regeneration following dental extraction. New bone graft substitutes are compared with already existing treatment principles used following dental extraction.

The primary hypothesis of the study is that Adaptos®-Si granules can reach a clinical outcome superior to that of dental socket left empty after extraction. Secondary aim is that new bioceramic composites can reach a clinical outcome non inferior to the active comparator of this study (Geistlisch Bio-Oss®).

Full description

The purpose of this study is to evaluate new synthetic Adaptos®-Si and Adaptos® in ridge preservation bone grafting after dental extraction. This is partly randomized, subject and outcome assessor-blinded, controlled, single center study. The total study duration for each patient is planned to be 10 months. In total 4 visits per patient are scheduled in this study.

Subjects will undergo a single tooth extraction and then will be randomized to receive one of the four bone graft substitutes, which are Adaptos®-Si (one of the the two granula sizes), Adaptos®, or Geistlich Bio-Oss®. Gelatin sponge is applied on the bone graft filled extraction socket. Non-randomized part of the study includes the patients that have chosen the conservative treatment option with dental socket left empty and no intention for dental implant placement. Following a healing period of 5 months, a dental implant will be placed, unless the patient has chosen the empty socket. The subject will be followed for ten months following tooth extraction. Bone ridge horizontal and vertical change assessment will be done by CBCT (primary and secondary outcome) at the time of tooth extraction, and 5 months and 10 months post-extraction.

The study device Bio-Oss® (Geistlich Pharma) and Spongostan Absorbable Haemostatic Gelatin Sponge (Ferrosan Medical Devices) are CE-marked. The products are used within the indication.

Enrollment: 76 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient must have voluntarily signed the informed consent
• Females and males, 18 years to 80 years of age
• Patient needs single tooth extraction of 1st or 2nd premolar or molar tooth
• At least one adjacent teeth present
• At least 3 intact walls
• Subjects must be committed to the study and the required follow-up visits

Exclusion criteria

• Planned radiation or radiation during previous year in the tooth extraction area.
• Smoking
• Osteoporosis
• Uncontrolled periodontitis
• Alcohol or drug abuse
• Pregnant or breastfeeding women
• Uncontrolled diabetes
• Local acute or chronic infection or presence of oral lesions or trauma
• Immunosuppressive disease, treatment, or medication
• Subject is part of the investigator team of this study or investigator's family member
• Subject is employee of one of the organizations involve in this study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

76 participants in 5 patient groups, including a placebo group

Adaptos-Si [0.5-1 mm]

Experimental group

Description:

Bone augmentation, after tooth extraction, with Adaptos-Si \[0.5-1 mm\] (synthetic bone graft material) in combination with a gelatin sponge.

Treatment:

Device: Adaptos®-Si [0.5-1 mm] (bone grafting surgery)

Adaptos-Si [1-2 mm]

Experimental group

Description:

Bone augmentation, after tooth extraction, with Adaptos-Si \[1-2 mm\] (synthetic bone graft material) in combination with a gelatin sponge.

Treatment:

Device: Adaptos®-Si [1-2 mm] (bone grafting surgery)

Bio-Oss

Active Comparator group

Description:

Bone augmentation, after tooth extraction, with Bio-Oss (bovine-derived xenograft) in combination with a gelatin sponge.

Treatment:

Device: Geistlich Bio-Oss (bone grafting surgery)

Empty extraction socket

Placebo Comparator group

Description:

Post-extraction the socket filled only by clot.

Treatment:

Procedure: Tooth extraction without bone graft material

Adaptos [1-2 mm]

Experimental group

Description:

Bone augmentation, after tooth extraction, with Adaptos \[1-2 mm\] (synthetic bone graft material) in combination with a gelatin sponge.

Treatment:

Device: Adaptos® (bone grafting surgery)